Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Evan C Chen
Dana-Farber - Harvard Cancer Center LAO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Yale University
New Haven, Connecticut, United States
Maximilian StahlRecruiting - Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
Michael J. HochmanRecruiting - University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Olatoyosi M. OdenikeRecruiting - Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
Suspended - University of Chicago Medicine-Orland Park
Orland Park, Illinois, United States
Suspended - Uchicago Medicine Northwest Indiana
Crown Point, Indiana, United States
Suspended - University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
Vu H. DuongRecruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Evan C. ChenRecruiting - Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
Meagan JacobyRecruiting - Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
Meagan JacobyRecruiting - Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
Meagan JacobyRecruiting - Siteman Cancer Center-South County
St Louis, Missouri, United States
Meagan JacobyRecruiting - Washington University School of Medicine
St Louis, Missouri, United States
Meagan JacobyRecruiting - Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
Tamanna HaqueRecruiting - Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
Tamanna HaqueRecruiting - Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
Tamanna HaqueRecruiting - Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Neil D. PalmisianoRecruiting - Memorial Sloan Kettering Commack
Commack, New York, United States
Tamanna HaqueRecruiting - Memorial Sloan Kettering Westchester
Harrison, New York, United States
Tamanna HaqueRecruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Tamanna HaqueRecruiting - Memorial Sloan Kettering Nassau
Uniondale, New York, United States
Tamanna HaqueRecruiting - Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Madelyn BurkartRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2025
- Primary completion
- 1 Jun 2028
- Completion
- 1 Jun 2028
- Last update posted
- 11 Jun 2026
- Registered enrollment
- 54
- Registry id
- NCT06484062
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.